Paper4479366
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.
Mouridsen HT and 2 others. Acta Pharmacol Toxicol (Copenh), 1974. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects. Papers, record 4479366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4479366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Analysis of Variance | |
| Biotransformation | |
| Body Weight | |
| Carbon Radioisotopes | |
| Chromatography, Thin Layer | |
| Female | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Methods | |
| Middle Aged | |
| Sex Factors | |
| Time Factors |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16231966 | Clinical pharmacokinetics of cyclophosphamide. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16231966 | PubMed |
| 9924440 | Proposal for the assessment of quantitative dermal exposure limits in occupational environments: Part 1. Development of a concept to derive a quantitative dermal occupational exposure limit. | Occup Environ Med | 1998 | https://conductscience.org/library/papers/9924440 | PubMed |
| 7358774 | [Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)]. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7358774 | PubMed |
| 7307230 | Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7307230 | PubMed |
| 7127662 | Metabolism of high doses of cyclophosphamide. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7127662 | PubMed |
| 6882623 | Pharmacokinetics of cyclophosphamide in Kenyan Africans. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6882623 | PubMed |
| 6640827 | Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6640827 | PubMed |
| 6469516 | Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6469516 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 3757157 | Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3757157 | PubMed |
| 2661198 | Problems in the use of anticancer drugs in the elderly. | Drugs | 1989 | https://conductscience.org/library/papers/2661198 | PubMed |
| 1553250 | Detection of contamination with antineoplastic agents in a hospital pharmacy department. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1553250 | PubMed |
| 791322 | The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/791322 | PubMed |
| 638469 | Haemodialysis during cyclophosphamide treatment. | Br Med J | 1978 | https://conductscience.org/library/papers/638469 | PubMed |
| 535136 | The disposition of cyclophosphamide in a group of myeloma patients. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/535136 | PubMed |
| 497087 | Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/497087 | PubMed |
| 389529 | Clinical pharmacokinetics of cyclophosphamide. | Clin Pharmacokinet | 1979 | https://conductscience.org/library/papers/389529 | PubMed |
| 114397 | Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients. | Eur J Drug Metab Pharmacokinet | 1979 | https://conductscience.org/library/papers/114397 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4479366
GET https://conductscience.org/api/papers/v1/4479366/authors